You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your inbox on Tuesdays and Thursdays.
On the hot seat, feeling the Bern
Drug executives will soon have the chance to tell Congress why they’re suing Medicare over price negotiations when their companies sell drugs to all the other governments that negotiate prices, my colleague John Wilkerson reports.
Senate health committee Chair Bernie Sanders (I-Vt.) said he wants executives of companies that have sued to be among the witnesses at an upcoming hearing on drug prices. His office has started calling those folks to work on scheduling, but formal invitations have not gone out yet.
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect